Similar Articles
341 Histone deacetylase inhibitors and pancreatic cancer: Are there any promising clinical trials?
342 Current developments, problems and solutions in the non-surgical treatment of pancreatic cancer
343 Current evidence for histone deacetylase inhibitors in pancreatic cancer
344 Complexity of molecular alterations impacts pancreatic cancer prognosis
345 Sister Mary Joseph’s nodule as a first sign of pancreatic cancer
346 Insights into erlotinib action in pancreatic cancer cells using a combined experimental and mathematical approach
347 Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?
348 Role of taxanes in pancreatic cancer
349 Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer
350 Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA